SCHEMBL2342043

SCHEMBL2342043

COc1ccc(-n2c(N3CCNCC3)cc3ccccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 5/20 0.56
▸ ADRB1 P08588 3/20 0.56
▸ HTR3E A5X5Y0 3/20 0.56
▸ HTR3B O95264 3/20 0.56
▸ HTR3D Q70Z44 3/20 0.56
▸ HTR3C Q8WXA8 3/20 0.56
▸ SIGMAR1 Q99720 2/20 0.56
▸ HTR1A P08908 3/20 0.51
▸ HTR1D P28221 1/20 0.51
▸ HTR1B P28222 1/20 0.51
▸ HTR5A P47898 1/20 0.48
▸ HTR7 P34969 1/20 0.47
▸ HTR2C P28335 2/20 0.46
▸ CYP1A2 P05177 4/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ CASP1 P29466 3/20 0.45
▸ CASP7 P55210 3/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ USP2 O75604 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2348220 0.89 ADRB1 (0.62) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL11555106 0.85 HTR3E (0.53) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2346369 0.83 ADRB1 (0.53) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2345082 0.83 HTR3E (0.48) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2348309 0.82 HTR3A (0.44) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2346242 0.78 ADRB1 (0.60) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2345155 0.75 HTR1A (0.44) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2343308 0.75 SOS1 (0.47) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL2410870 0.74 ADRB1 (1.00) HTR3AADRB1HTR3EHTR3BHTR3D
SCHEMBL234280 0.74 ADRB1 (1.00) HTR3AADRB1HTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback